Targeting Metabolic Dysfunction and Inflammation with Sotagliflozin Reverses Diastolic Dysfunction in Experimental HFpEF
Parisa Shabani, Tahra Kaur Luther, Rajesh Kumar Chaudhary, Anand Prakash Singh, Afnan Alzamrooni, Olga G. Grushko, Nathan Levine, Rachel Lopez‐Schenk, Sascha N Goonwardena, Bertram Pitt, Ahmed Abdel‐Latif
This study shows that sotagliflozin improves diastolic dysfunction in HFpEF by enhancing lipid metabolism and reducing inflammation.
bioRxiv · Nov 27, 2025 · PreprintCell Biology